Pregnancy

Indinavir (Crixivan) is not recommended for pregnant women, following the observation that pregnant women have substantially reduced concentrations of indinavir in the blood at weeks 30 to 32 of pregnancy. This increases the risk of the development of resistance and treatment failure, as well as mother-to-child transmission of HIV during childbirth.

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.